Skip to main content
. 2023 Oct 18;12(10):1875. doi: 10.3390/antiox12101875

Table 1.

Clinical and biochemical parameters in patients with psoriasis versus atopic dermatitis.

Parameter PsO AD p
Sex
men, n (%) 22 (55) 18 (45) 0.251
women, n (%) 18 (45) 22 (55)
Age (years) 50 (39–67) 42 (34–51) 0.011
BMI (kg/m2) 27.0 (24.0–30.8) 23.8 (21.7–25.0) <0.001
Smoking, n (%)
No 22 (55) 23 (58) 0.500
Yes 18 (45) 17 (42)
Disease duration (years) 8.0 (5.0–13.5) 10 (5.0–17.5) 0.284
Intensity of itch 6.0 (5.0–8.0) 8.0 (7.5–9.0) 0.004
Therapy local, n (%) 30 (75.0) 38 (95.0) 0.013
Methotrexate, n (%) 10 (25.0) 2 (5%)
Comorbidities
No 19 (47.5) 20 (50.0) 0.500
Yes 21 (52.5) 20 (50.0)
Glucose (mmol/L) 5.3 (4.9–5.9) 5.2 (4.9–5.4) 0.178
TC (mmol/L) 5.02 (4.39–6.12) 4.60 (4.06–5.26) 0.227
HDL-c (mmol/L) 1.37 (1.09–1.63) 1.54 (1.22–1.63) 0.233
LDL-c (mmol/L) 2.88 (2.14–3.62) 2.47 (2.14–3.54) 0.564
TG (mmol/L) 1.68 (0.93–2.34) 1.13 (0.75–1.90) 0.114
MDA (μmol/L) 4.00 (1.67–7.49) 5.15 (2.85–8.62) 0.146
AOPP (μmol/L) 909 (676–1035) 1086 (724–1300) 0.145
SOD (U/mL) 6.19 (5.94–6.44) 6.00 (5.75–6.38) 0.162
CAT (U/L) 0.412 (0.383–0.478) 0.521 (0.420–0.706) <0.001